Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.
about
Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Recombinant methioninase combi ...... xenograft (PDOX) mouse model.
@en
Recombinant methioninase combined with doxorubicin
@nl
type
label
Recombinant methioninase combi ...... xenograft (PDOX) mouse model.
@en
Recombinant methioninase combined with doxorubicin
@nl
prefLabel
Recombinant methioninase combi ...... xenograft (PDOX) mouse model.
@en
Recombinant methioninase combined with doxorubicin
@nl
P2093
P2860
P356
P1433
P1476
Recombinant methioninase combi ...... xenograft (PDOX) mouse model.
@en
P2093
Arun S Singh
Emily Gainor
Fritz C Eilber
Hiroaki Kimura
Hiromichi Oshiro
Hiroyuki Tsuchiya
Katsuhiro Hayashi
Kei Kawaguchi
Kentaro Miyake
Mark A Eckardt
P2860
P304
19263-19272
P356
10.18632/ONCOTARGET.24996
P407
P577
2018-04-10T00:00:00Z